University of Southern California, Los Angeles, California.
Neurourol Urodyn. 2013 Sep;32(7):1010-3. doi: 10.1002/nau.22345. Epub 2013 Apr 17.
Stress urinary incontinence (SUI) is a known possibility after radical cystectomy (RC) and orthotopic neobladder (ONB) urinary diversion. We retrospectively reviewed the outcomes and complications of patients who underwent artificial urinary sphincter (AUS) placement for treatment of SUI and evaluated potential risk factors (PRFs) for AUS failure.
Patients who underwent AUS placement after RC/ONB from 1994 to 2009 were identified. Variables evaluated included: demographics, cancer type, AUS characteristics, urinary incontinence (UI), revision procedures data, and PRFs for AUS failure.
Demographic data was reviewed on 36 patients. Mean age at AUS placement was 72 (58-79) years. Mean time to AUS after RC/ONB was 28 (2-120) months. Mean follow up after AUS was 40 (2-132) months. TCC was the indication for RC in 94% of patients. The most commonly placed AUS cuff and reservoir size was 4.5 cm and 61-70 H2 O, respectively. Incontinence data was available in 29 patients. Pre-AUS placement 22, 3, and 4 patients were totally, daytime and nighttime only incontinent, respectively. Post-AUS placement, incontinence persisted in 5, 1, and 2 patients with total, daytime and nighttime incontinence, respectively. Prior to AUS placement 11/36 patients received chemotherapy and 10/36 had radiation. Mean time to the first revision/explantation due to UI/erosion/infection/malfunction was an average of 28 (3-96) months after AUS placement and occurred in 21/35 (60%) patients. There was no significant correlation noted between PRFs and UI pre-/post-AUS or between PRFs and the need for AUS revision.
AUS is a safe, effective treatment with an acceptable complication rate for patients after RC/ONB with SUI.
根治性膀胱切除术(RC)和原位新膀胱(ONB)尿流改道后,已知会发生压力性尿失禁(SUI)。我们回顾性分析了接受人工尿道括约肌(AUS)治疗 SUI 的患者的结果和并发症,并评估了 AUS 失败的潜在风险因素(PRF)。
从 1994 年到 2009 年,我们确定了接受 RC/ONB 后行 AUS 放置的患者。评估的变量包括:人口统计学、癌症类型、AUS 特征、尿失禁(UI)、修订程序数据和 AUS 失败的 PRF。
回顾了 36 例患者的人口统计学数据。AUS 放置时的平均年龄为 72(58-79)岁。RC/ONB 后至 AUS 的平均时间为 28(2-120)个月。AUS 后平均随访时间为 40(2-132)个月。94%的患者因膀胱癌接受 RC。最常放置的 AUS 袖套和储液器尺寸分别为 4.5cm 和 61-70 H2O。29 例患者有尿失禁数据。AUS 放置前,22、3 和 4 例患者分别完全、白天和仅夜间失禁。AUS 放置后,5 例、1 例和 2 例患者分别持续完全、白天和夜间失禁。AUS 放置前,36 例患者中有 11 例接受化疗,10 例接受放疗。AUS 放置后平均 28(3-96)个月因 UI/侵蚀/感染/故障需要首次翻修/取出,35 例患者中有 21 例(60%)发生。AUS 前后 UI 或 AUS 前后 PRF 与 UI 之间或 PRF 与 AUS 修订之间均无显著相关性。
AUS 是 RC/ONB 后 SUI 患者安全、有效且并发症发生率可接受的治疗方法。